Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Video Expert Opinion
Round Table Discussions
Sign in
Join now
David Henry MD
David Henry MD Advisory Board
Guru Sonpavde MD
Guru P. Sonpavde MD Advisory Board
Rafael Fonseca MD
Rafael Fonseca MD Editor-in-Chief
See All Experts
featured
Published in Oncology and
1 other channel

Expert Opinion / Interview · February 25, 2019

Ipilimumab Plus Nivolumab for mCRPC

Farzanna Haffizulla MD, FACP, FAMWA
Tanya Dorff MD
Interview with
Tanya B Dorff MD

 

 Save  Recommend
 Share

Further Reading

Most Watched This Week

Related Videos